Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NYSE:MRK
Tag: NYSE:MRK
Merck & Co., Inc. (NYSE:MRK) Strengthens Immuno-Oncology Portfolio With Rigontec Acquisition
Andy Parker
-
September 11, 2017
0
AstraZeneca plc (ADR) (NYSE:AZN) Still Confident About Its Lung Cancer Treatment...
-
August 8, 2017
0
Merck & Company, Inc. (NYSE:MRK) reported earnings of $1.01 per share...
ME Staff
-
July 28, 2017
0
Samsung And Merck & Co., Inc. (NYSE:MRK) Launch Biosimilar For Arthritis
-
July 25, 2017
0
FDA Rejects Amgen, Inc. (NASDAQ:AMGN) Osteoporosis Drug, Requests More Data
-
July 18, 2017
0
Novartis AG (ADR) (NYSE:NVS) Just Took A Big Step Forward In...
-
July 13, 2017
0
Bristol-Myers Squibb Co (NYSE:BMY) Hints At $1 billion Sales After Topline...
Andy Parker
-
July 6, 2017
0
Biotech Movers: Bristol-Myers Squibb Company (NYSE:BMY) and Merck (NYSE:MRK)
-
July 6, 2017
0
GlaxoSmithKline plc. (ADR)(NYSE:GSK) Inks $43 Million Artificial Intelligence Deal To Develop...
-
July 5, 2017
0
Merck & Co., Inc. (NYSE:MRK) Cholesterol Drug Anacetrapib Meets Primary Endpoint
-
June 29, 2017
0
1
...
3
4
5
...
10
Page 4 of 10
